BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37999872)

  • 1. Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Alhajahjeh A; Nazha A
    Curr Hematol Malig Rep; 2024 Feb; 19(1):9-17. PubMed ID: 37999872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome.
    Iacobucci I; Mullighan CG
    Curr Opin Hematol; 2021 Mar; 28(2):101-109. PubMed ID: 33427759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics and molecular genetics of myelodysplastic neoplasms.
    Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility and real-world application of molecular genetic sequencing in the management of patients with acute myeloid leukemia and myelodysplastic syndromes.
    Banaszak LG; Reinig E; Lasarev MR; Mattison RJ
    Leuk Lymphoma; 2022 Mar; 63(3):684-693. PubMed ID: 34865601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial myelodysplastic syndrome/acute myeloid leukemia.
    Churpek JE
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.
    West AH; Godley LA; Churpek JE
    Ann N Y Acad Sci; 2014 Mar; 1310(1):111-8. PubMed ID: 24467820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges.
    Xue Y; Xia X; Liu X; Zheng Y; Gu H; Wang X
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):86. PubMed ID: 38420833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
    Tawana K; Drazer MW; Churpek JE
    Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When to use which molecular prognostic scoring system in the management of patients with MDS?
    Kewan T; Bewersdorf JP; Gurnari C; Xie Z; Stahl M; Zeidan AM
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101517. PubMed ID: 38092484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does mutational burden add to other prognostic factors in MDS?
    Nazha A
    Best Pract Res Clin Haematol; 2019 Dec; 32(4):101098. PubMed ID: 31779975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in acute leukemia and myelodysplasia.
    Carraway HE; Pollyea DA; Stein EM
    Best Pract Res Clin Haematol; 2022 Dec; 35(4):101415. PubMed ID: 36517125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Nardi V; Hasserjian RP
    Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes.
    Yanada M; Mizuno S; Yamasaki S; Harada K; Konuma T; Tamaki H; Shingai N; Uchida N; Ozawa Y; Tanaka M; Onizuka M; Sawa M; Nakamae H; Shiratori S; Matsuoka KI; Eto T; Kawakita T; Maruyama Y; Ichinohe T; Kanda Y; Atsuta Y; Aoki J; Yano S
    Leuk Lymphoma; 2021 Dec; 62(14):3411-3419. PubMed ID: 34348554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Zavras PD; Sinanidis I; Tsakiroglou P; Karantanos T
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision Medicine in Myeloid Malignancies: Hype or Hope?
    Upadhyay Banskota S; Khanal N; Marar RI; Dhakal P; Bhatt VR
    Curr Hematol Malig Rep; 2022 Dec; 17(6):217-227. PubMed ID: 35972641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.